CHARACTERISTICS AND COMPLICATIONS OF TUMOR LYSIS SYNDROME IN HEMATOLOGIC MALIGNANCIES

被引：0

作者：

Roy, Arya Mariam ^{[1
]}

Konda, Manojna ^{[1
]}

Goel, Akshay ^{[1
]}

Meena, Nikhil ^{[2
]}

机构：

[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[2] Univ Arkansas Med Sci, Med Ctr, Little Rock, AR 72205 USA

来源：

CRITICAL CARE MEDICINE | 2020年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

525

引用

页数：1

共 50 条

[21] Recombinant urate oxidase (Rasburicase): A new targeted therapy for prophylaxis and treatment of patients with hematologic malignancies at risk of tumor lysis syndrome [J].

Cairo, MS .

CLINICAL LYMPHOMA, 2003, 3 (04) :233-234

[22] Pharmacokinetic analysis of two dose levels of rasburicase in adult patients with hematologic malignancies at high or potential risk for tumor lysis syndrome [J].

Huen, A. ;

DeAngelo, D. ;

Fanale, M. ;

Vadhan-Raj, S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[23] Uric acid (UA) level is a significant and independent prognostic factor in the development of tumor lysis syndrome (TLS) snd renal complications in patients with hematologic malignancies admitted for chemotherapy. [J].

Cairo, MS ;

Arikian, S ;

Casciano, R ;

Stern, L ;

Morris, E ;

Yaish, HM ;

Doyle, J .

BLOOD, 2002, 100 (11) :284B-284B

[24] Description and Characteristics of Ocular Tumor Lysis Syndrome [J].

de Carlo Forest, Talisa E. ;

Oliver, Scott C. N. .

OCULAR ONCOLOGY AND PATHOLOGY, 2024, 10 (03) :139-145

[25] Management of bleeding complications of hematologic malignancies [J].

Green, David .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04) :427-434

[26] Bleeding Complications in Patients with Hematologic Malignancies [J].

Franchini, Massimo ;

Frattini, Francesco ;

Crestani, Silvia ;

Bonfanti, Carlo .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (01) :94-100

[27] Thromboembolic complications in pediatric hematologic malignancies [J].

Athale, Uma H. ;

Chan, Anthony K. C. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04) :416-426

[28] Predictors of Mortality and Readmission for Tumor Lysis Syndrome Hospitalizations in Lymphoid Malignancies [J].

Balasubramanian, Shiva ;

Wang, Xi ;

Cheng, An-Lin ;

Shrestha, Anuj .

BLOOD, 2024, 144 :7606-7606

[29] TUMOR LYSIS SYNDROME IN NONHEMATOLOGIC MALIGNANCIES - REPORT OF A CASE AND REVIEW OF THE LITERATURE [J].

DRAKOS, P ;

BARZIV, J ;

CATANE, R .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06) :502-505

[30] Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China [J].

Hu, Shaoyan ;

Han, Yi ;

Zhang, Wenjie ;

Zhang, Tianxiang ;

Yao, Xingxing ;

Liu, Li .

JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) :742-750

← 1 2 3 4 5 →